Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: BLADDER CANCER, . Treffer: 68

2020

Barth, DA; Juracek, J; Slaby, O; Pichler, M; Calin, GA lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System.
Cancers (Basel). 2020; 12(8):
PubMed FullText FullText_MUG

 

Bekric, D; Neureiter, D; Ritter, M; Jakab, M; Gaisberger, M; Pichler, M; Kiesslich, T; Mayr, C Long Non-Coding RNAs in Biliary Tract Cancer-An Up-to-Date Review.
J Clin Med. 2020; 9(4): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Soukup, V; Capoun, O; Cohen, D; Hernandez, V; Burger, M; Comperat, E; Gontero, P; Lam, T; Mostafid, AH; Palou, J; van Rhijn, BWG; Roupret, M; Shariat, SF; Sylvester, R; Yuan, YH; Zigeuner, R; Babjuk, M Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel
EUR UROL FOCUS. 2020; 6(3): 479-489.
Web of Science PubMed FullText FullText_MUG

 

Witjes, JA; Babjuk, M; Bellmunt, J; Bruins, HM; De Reijke, TM; De Santis, M; Gillessen, S; James, N; Maclennan, S; Palou, J; Powles, T; Ribal, MJ; Shariat, SF; Van der Kwast, T; Xylinas, E; Agarwal, N; Arends, T; Bamias, A; Birtle, A; Black, PC; Bochner, BH; Bolla, M; Boormans, JL; Bossi, A; Briganti, A; Brummelhuis, I; Burger, M; Castellano, D; Cathomas, R; Chiti, A; Choudhury, A; Comperat, E; Crabb, S; Culine, S; De Bari, B; De Blok, W; De Visschere, PJL; Decaestecker, K; Dimitropoulos, K; Dominguez-Escrig, JL; Fanti, S; Fonteyne, V; Frydenberg, M; Futterer, JJ; Gakis, G; Geavlete, B; Gontero, P; Grubmuller, B; Hafeez, S; Hansel, DE; Hartmann, A; Hayne, D; Henry, AM; Hernandez, V; Herr, H; Herrmann, K; Hoskin, P; Huguet, J; Jereczek-Fossa, BA; Jones, R; Kamat, AM; Khoo, V; Kiltie, AE; Krege, S; Ladoire, S; Lara, PC; Leliveld, A; Linares-Espinos, E; Logager, V; Lorch, A; Loriot, Y; Meijer, R; Mir, MC; Moschini, M; Mostafid, H; Muller, AC; Muller, CR; N'Dow, J; Necchi, A; Neuzillet, Y; Oddens, JR; Oldenburg, J; Osanto, S; Oyen, WJG; Pacheco-Figueiredo, L; Pappot, H; Patel, MI; Pieters, BR; Plass, K; Remzi, M; Retz, M; Richenberg, J; Rink, M; Roghmann, F; Rosenberg, JE; Roupret, M; Rouviere, O; Salembier, C; Salminen, A; Sargos, P; Sengupta, S; Sherif, A; Smeenk, RJ; Smits, A; Stenzl, A; Thalmann, GN; Tombal, B; Turkbey, B; Lauridsen, SV; Valdagni, R; Van der Heijden, AG; Van Poppel, H; Vartolomei, MD; Veskimae, E; Vilaseca, A; Rivera, FAV; Wiegel, T; Wiklund, P; Williams, A; Zigeuner, R; Horwich, A EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees
EUR UROL. 2020; 77(2): 223-250. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Babjuk, M; Burger, M; Comperat, EM; Gontero, P; Mostafid, AH; Palou, J; van Rhijn, BWG; Roupret, M; Shariat, SF; Sylvester, R; Zigeuner, R; Capoun, O; Cohen, D; Escrig, JLD; Hernandez, V; Peyronnet, B; Seisen, T; Soukup, V European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update
EUR UROL. 2019; 76(5): 639-657.
Web of Science PubMed FullText FullText_MUG

 

Compérat, EM; Burger, M; Gontero, P; Mostafid, AH; Palou, J; Rouprêt, M; van Rhijn, BWG; Shariat, SF; Sylvester, RJ; Zigeuner, R; Babjuk, M Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".
Eur Urol Focus. 2019; 5(3):457-466
PubMed FullText FullText_MUG

 

Golob-Schwarzl, N; Wodlej, C; Kleinegger, F; Gogg-Kamerer, M; Birkl-Toeglhofer, AM; Petzold, J; Aigelsreiter, A; Thalhammer, M; Park, YN; Haybaeck, J Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer.
J Cancer Res Clin Oncol. 2019; 145(11): 2699-2711. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Horwich, A; Babjuk, M; Bellmunt, J; Bruins, HM; De Reijke, TM; De Santis, M; Gillessen, S; James, N; Maclennan, S; Palou, J; Powles, T; Ribal, MJ; Shariat, SF; Van der Kwast, T; Xylinas, E; Agarwal, N; Arends, T; Bamias, A; Birtle, A; Black, PC; Bochner, BH; Bolla, M; Boormans, JL; Bossi, A; Briganti, A; Brummelhuis, I; Burger, M; Castellano, D; Cathomas, R; Chiti, A; Choudhury, A; Comperat, E; Crabb, S; Culine, S; De Bari, B; De Blok, W; De Visschere, PJL; Decaestecker, K; Dimitropoulos, K; Dominguez-Escrig, JL; Fanti, S; Fonteyne, V; Frydenberg, M; Futterer, JJ; Gakis, G; Geavlete, B; Gontero, P; Grubmuller, B; Hafeez, S; Hansel, DE; Hartmann, A; Hayne, D; Henry, AM; Hernandez, V; Herr, H; Herrmann, K; Hoskin, P; Huguet, J; Jereczek-Fossa, BA; Jones, R; Kamat, AM; Khoo, V; Kiltie, AE; Krege, S; Ladoire, S; Lara, PC; Leliveld, A; Linares-Espinos, E; Logager, V; Lorch, A; Loriot, Y; Meijer, R; Mir, MC; Moschini, M; Mostafid, H; Muller, AC; Muller, CR; N'Dow, J; Necchi, A; Neuzillet, Y; Oddens, JR; Oldenburg, J; Osanto, S; Oyen, WJG; Pacheco-Figueiredo, L; Pappot, H; Patel, MI; Pieters, BR; Plass, K; Remzi, M; Retz, M; Richenberg, J; Rink, M; Roghmann, F; Rosenberg, JE; Roupret, M; Rouviere, O; Salembier, C; Salminen, A; Sargos, P; Sengupta, S; Sherif, A; Smeenk, RJ; Smits, A; Stenzl, A; Thalmann, GN; Tombal, B; Turkbey, B; Lauridsen, SV; Valdagni, R; Van der Heijden, AG; Van Poppel, H; Vartolomei, MD; Veskimae, E; Vilaseca, A; Rivera, FAV; Wiegel, T; Wiklund, P; Williams, A; Zigeuner, R; Witjes, JA EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
ANN ONCOL. 2019; 30(11): 1697-1727. [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Kleinegger, F; Hofer, E; Wodlej, C; Golob-Schwarzl, N; Birkl-Toeglhofer, AM; Stallinger, A; Petzold, J; Orlova, A; Krassnig, S; Reihs, R; Niedrist, T; Mangge, H; Park, YN; Thalhammer, M; Aigelsreiter, A; Lax, S; Garbers, C; Fickert, P; Rose-John, S; Moriggl, R; Rinner, B; Haybaeck, J Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
Biochim Biophys Acta Mol Basis Dis. 2019; 1865(2):308-321 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Mischinger, J; Abdelhafez, MF; Rausch, S; Todenhöfer, T; Neumann, E; Aufderklamm, S; Stenzl, A; Gakis, G Perioperative morbidity, bowel function and oncologic outcome after radical cystectomy and ileal orthotopic neobladder reconstruction: Studer-pouch versus I-pouch.
Eur J Surg Oncol. 2018; 44(1):178-184
Web of Science PubMed FullText FullText_MUG

 

Rouprêt, M; Babjuk, M; Compérat, E; Zigeuner, R; Sylvester, RJ; Burger, M; Cowan, NC; Gontero, P; Van Rhijn, BWG; Mostafid, AH; Palou, J; Shariat, SF European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
Eur Urol. 2018; 73(1):111-122
Web of Science PubMed FullText FullText_MUG

 

2017

Babjuk, M; Böhle, A; Burger, M; Capoun, O; Cohen, D; Compérat, EM; Hernández, V; Kaasinen, E; Palou, J; Rouprêt, M; van Rhijn, BW; Shariat, SF; Soukup, V; Sylvester, RJ; Zigeuner, R EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Eur Urol. 2017; 71(3):447-461
Web of Science PubMed FullText FullText_MUG

 

Mischinger, J; Guttenberg, LP; Hennenlotter, J; Gakis, G; Aufderklamm, S; Rausch, S; Neumann, E; Bedke, J; Kruck, S; Schwentner, C; Stenzl, A; Todenhöfer, T Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization.
J Cancer Res Clin Oncol. 2017; 143(4):677-685
Web of Science PubMed FullText FullText_MUG

 

Soukup, V; Čapoun, O; Cohen, D; Hernández, V; Babjuk, M; Burger, M; Compérat, E; Gontero, P; Lam, T; MacLennan, S; Mostafid, AH; Palou, J; van Rhijn, BWG; Rouprêt, M; Shariat, SF; Sylvester, R; Yuan, Y; Zigeuner, R Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
Eur Urol. 2017; 72(5):801-813
Web of Science PubMed FullText FullText_MUG

 

Weyerer, V; Schneckenpointner, R; Filbeck, T; Burger, M; Hofstaedter, F; Wild, PJ; Fine, SW; Humphrey, PA; Dehner, LP; Amin, MB; Rüschoff, J; Boltze, C; Tannapfel, A; Zwarthoff, E; Lopez-Beltran, A; Montironi, R; Langner, C; Stoehr, R; Hartmann, A; Giedl, J Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years.
J Cancer. 2017; 8(3):323-331 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Czink, E; Heining, C; Weber, TF; Lasitschka, F; Schemmer, P; Schirmacher, P; Weiss, KH; Glimm, H; Brors, B; Weichert, W; Jäger, D; Fröhling, S; Springfeld, C [Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer].
Z Gastroenterol. 2016; 54(5):426-430
Web of Science PubMed FullText FullText_MUG

 

Gakis, G; Efstathiou, JA; Daneshmand, S; Keegan, KA; Clayman, RH; Hrbacek, J; Ali-El-Dein, B; Zaid, HB; Schubert, T; Mischinger, J; Todenhöfer, T; Galland, S; Olugbade, K; Rink, M; Fritsche, HM; Burger, M; Chang, SS; Babjuk, M; Thalmann, GN; Stenzl, A; Morgan, TM Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma.
Urol Int. 2016; 97(2):134-141 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rausch, S; Hennenlotter, J; Scharpf, M; Teepe, K; Kühs, U; Aufderklamm, S; Bier, S; Mischinger, J; Gakis, G; Stenzl, A; Schwentner, C; Todenhöfer, T Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma.
J Cancer Res Clin Oncol. 2016; 142(5):937-947
Web of Science PubMed FullText FullText_MUG

 

Schrem, H; Schneider, V; Kurok, M; Goldis, A; Dreier, M; Kaltenborn, A; Gwinner, W; Barthold, M; Liebeneiner, J; Winny, M; Klempnauer, J; Kleine, M Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control.
PLoS One. 2016; 11(7): e0158732-e0158732. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schubert, T; Todenhöfer, T; Mischinger, J; Schwentner, C; Renninger, M; Stenzl, A; Gakis, G The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer.
World J Urol. 2016; 34(6):829-834
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Dorner, N; Kühs, U; Aufderklamm, S; Rausch, S; Bier, S; Mischinger, J; Schellbach, D; Hauch, S; Feniuk, N; Bedke, J; Gakis, G; Stenzl, A; Schwentner, C Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
J Cancer Res Clin Oncol. 2016; 142(5):1013-1020
Web of Science PubMed FullText FullText_MUG

 

2015

Amin, MB; Smith, SC; Reuter, VE; Epstein, JI; Grignon, DJ; Hansel, DE; Lin, O; McKenney, JK; Montironi, R; Paner, GP; Al-Ahmadie, HA; Algaba, F; Ali, S; Alvarado-Cabrero, I; Bubendorf, L; Cheng, L; Cheville, JC; Kristiansen, G; Cote, RJ; Delahunt, B; Eble, JN; Genega, EM; Gulmann, C; Hartmann, A; Langner, C; Lopez-Beltran, A; Magi-Galluzzi, C; Merce, J; Netto, GJ; Oliva, E; Rao, P; Ro, JY; Srigley, JR; Tickoo, SK; Tsuzuki, T; Umar, SA; Van der Kwast, T; Young, RH; Soloway, MS Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.
Mod Pathol. 2015; 28(5):612-630 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gakis, G; Ngamsri, T; Rausch, S; Mischinger, J; Todenhöfer, T; Schwentner, C; Schmid, MA; Hassan, FA; Renninger, M; Stenzl, A Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy.
World J Urol. 2015; 33(10):1429-1437
Web of Science PubMed FullText FullText_MUG

 

Messina, C; Dellepiane, C; Caroti, C; Sarocchi, F; Ravetti, GL; Boccardo, F; Spina, B A Case of Advanced Mucinous Adenocarcinoma of Bladder in an Adult Patient Treated With Capecitabine-Based Chemotherapy and Review of Literature.
Clin Genitourin Cancer. 2015; 13(5): e365-e368. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Mischinger, J; Abdelhafez, MF; Todenhöfer, T; Schwentner, C; Aufderklamm, S; Stenzl, A; Gakis, G Quality of life outcomes after radical cystectomy: long-term standardized assessment of Studer Pouch versus I-Pouch.
World J Urol. 2015; 33(10):1381-1387
Web of Science PubMed FullText FullText_MUG

 

Mischinger, J; Comperat, E; Schwentner, C; Stenzl, A; Gakis, G Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?
Curr Urol Rep. 2015; 16(9):59-59
Web of Science PubMed FullText FullText_MUG

 

Rausch, S; Hennenlotter, J; Teepe, K; Kuehs, U; Aufderklamm, S; Bier, S; Mischinger, J; Gakis, G; Stenzl, A; Schwentner, C; Todenhöfer, T Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
Urol Oncol. 2015; 33(10):426.e21-426.e29
Web of Science PubMed FullText FullText_MUG

 

Rouprêt, M; Babjuk, M; Compérat, E; Zigeuner, R; Sylvester, RJ; Burger, M; Cowan, NC; Böhle, A; Van Rhijn, BW; Kaasinen, E; Palou, J; Shariat, SF European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Eur Urol. 2015; 68(5):868-879
Web of Science PubMed FullText FullText_MUG

 

2014

Dalpiaz, O; Ehrlich, G; Quehenberger, F; Pummer, K; Zigeuner, R Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter.
Urol Oncol. 2014; 32(1):34.e1-34.e8
Web of Science PubMed FullText FullText_MUG

 

Nersesyan, A; Kundi, M; Fenech, M; Bolognesi, C; Misik, M; Wultsch, G; Hartmann, M; Knasmueller, S Micronucleus assay with urine derived cells (UDC): a review of its application in human studies investigating genotoxin exposure and bladder cancer risk.
Mutat Res Rev Mutat Res. 2014; 762:37-51
Web of Science PubMed FullText FullText_MUG

 

Spilka, R; Ernst, C; Bergler, H; Rainer, J; Flechsig, S; Vogetseder, A; Lederer, E; Benesch, M; Brunner, A; Geley, S; Eger, A; Bachmann, F; Doppler, W; Obrist, P; Haybaeck, J eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation.
Cell Oncol (Dordr). 2014; 37(4):253-267
Web of Science PubMed FullText FullText_MUG

 

Todenhofer, T; Hennenlotter, J; Esser, M; Mohrhardt, S; Aufderklamm, S; Bottge, J; Rausch, S; Mischinger, J; Bier, S; Gakis, G; Kuehs, U; Stenzl, A; Schwentner, C Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer
DIS MARKERS. 2014; 973406 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Xylinas, E; Rink, M; Cha, EK; Clozel, T; Lee, RK; Fajkovic, H; Comploj, E; Novara, G; Margulis, V; Raman, JD; Lotan, Y; Kassouf, W; Fritsche, HM; Weizer, A; Martinez-Salamanca, JI; Matsumoto, K; Zigeuner, R; Pycha, A; Scherr, DS; Seitz, C; Walton, T; Trinh, QD; Karakiewicz, PI; Matin, S; Montorsi, F; Zerbib, M; Shariat, SF; Upper Tract Urothelial Carcinoma Collaboration Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Eur Urol. 2014; 65(1):210-217
Web of Science PubMed FullText FullText_MUG

 

2013

Babjuk, M; Burger, M; Zigeuner, R; Shariat, SF; van Rhijn, BW; Compérat, E; Sylvester, RJ; Kaasinen, E; Böhle, A; Palou Redorta, J; Rouprêt, M; European Association of Urology EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Eur Urol. 2013; 64(4):639-653
Web of Science PubMed FullText FullText_MUG

 

Chromecki, TF; Cha, EK; Fajkovic, H; Rink, M; Ehdaie, B; Svatek, RS; Karakiewicz, PI; Lotan, Y; Tilki, D; Bastian, PJ; Daneshmand, S; Kassouf, W; Durand, M; Novara, G; Fritsche, HM; Burger, M; Izawa, JI; Brisuda, A; Babjuk, M; Pummer, K; Shariat, SF Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
BJU Int. 2013; 111(2):249-255 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fajkovic, H; Cha, EK; Jeldres, C; Robinson, BD; Rink, M; Xylinas, E; Chromecki, TF; Breinl, E; Svatek, RS; Donner, G; Tagawa, ST; Tilki, D; Bastian, PJ; Karakiewicz, PI; Volkmer, BG; Novara, G; Joual, A; Faison, T; Sonpavde, G; Daneshmand, S; Lotan, Y; Scherr, DS; Shariat, SF Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Eur Urol. 2013; 64(5):837-845
Web of Science PubMed FullText FullText_MUG

 

Horstmann, M; Todenhöfer, T; Hennenlotter, J; Aufderklamm, S; Mischinger, J; Kuehs, U; Gakis, G; Stenzl, A; Schwentner, C Influence of age on false positive rates of urine-based tumor markers.
World J Urol. 2013; 31(4):935-940
Web of Science PubMed FullText FullText_MUG

 

2012

Barbieri, CE; Cha, EK; Chromecki, TF; Dunning, A; Lotan, Y; Svatek, RS; Scherr, DS; Karakiewicz, PI; Sun, M; Mazumdar, M; Shariat, SF Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.
BJU Int. 2012; 109(5): 685-690. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Chromecki, TF; Cha, EK; Fajkovic, H; Margulis, V; Novara, G; Scherr, DS; Lotan, Y; Raman, JD; Kassouf, W; Bensalah, K; Weizer, A; Kikuchi, E; Roscigno, M; Remzi, M; Matsumoto, K; Walton, TJ; Pycha, A; Ficarra, V; Karakiewicz, PI; Zigeuner, R; Pummer, K; Shariat, SF The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
Eur Urol. 2012; 61(2): 245-253.
Web of Science PubMed FullText FullText_MUG

 

Golka, K; Abreu-Villaca, Y; Anbari Attar, R; Angeli-Greaves, M; Aslam, M; Basaran, N; Belik, R; Butryee, C; Dalpiaz, O; Dzhusupov, K; Ecke, TH; Galambos, H; Galambos, H; Gerilovica, H; Gerullis, H; Gonzalez, PC; Goossens, ME; Gorgishvili-Hermes, L; Heyns, CF; Hodzic, J; Ikoma, F; Jichlinski, P; Kang, BH; Kiesswetter, E; Krishnamurthi, K; Lehmann, ML; Martinova, I; Mittal, RD; Ravichandran, B; Romics, I; Roy, B; Rungkat-Zakaria, F; Rydzynski, K; Scutaru, C; Shen, J; Soufi, M; Toguzbaeva, K; Vu Duc, T; Widera, A; Wishahi, M; Hengstler, JG Bladder cancer documentation of causes: multilingual questionnaire, 'bladder cancer doc'.
Front Biosci (Elite Ed). 2012; 4(9):2809-2822
PubMed

 

Rink, M; Chun, FK; Chromecki, TF; Fajkovic, H; Dahlem, R; Fisch, M; Shariat, SF Advanced bladder cancer in elderly patients : Prognostic outcomes and therapeutic strategies.
Urologe A. 2012; 51(6):820-828
Web of Science PubMed FullText FullText_MUG

 

Roupret, M; Zigeuner, R; Palou, J; Boehle, A; Kaasinen, E; Sylvester, R; Babjuk, M; Oosterlinck, W; European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract.
Actas Urol Esp. 2012; 36(1): 2-14. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Shariat, SF; Ehdaie, B; Rink, M; Cha, EK; Svatek, RS; Chromecki, TF; Fajkovic, H; Novara, G; David, SG; Daneshmand, S; Fradet, Y; Lotan, Y; Sagalowsky, AI; Clozel, T; Bastian, PJ; Kassouf, W; Fritsche, HM; Burger, M; Izawa, JI; Tilki, D; Abdollah, F; Chun, FK; Sonpavde, G; Karakiewicz, PI; Scherr, DS; Gonen, M Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.
Eur Urol. 2012; 61(2): 237-242. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Fajkovic, H; Halpern, JA; Cha, EK; Bahadori, A; Chromecki, TF; Karakiewicz, PI; Breinl, E; Merseburger, AS; Shariat, SF Impact of gender on bladder cancer incidence, staging, and prognosis.
WORLD J UROL. 2011; 29(4): 457-463.
Web of Science PubMed FullText FullText_MUG

 

Matsushita, K; Cha, EK; Matsumoto, K; Baba, S; Chromecki, TF; Fajkovic, H; Sun, M; Karakiewicz, PI; Scherr, DS; Shariat, SF Immunohistochemical biomarkers for bladder cancer prognosis.
INT J UROL. 2011; 18(9): 616-629. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Putluri, N; Shojaie, A; Vasu, VT; Vareed, SK; Nalluri, S; Putluri, V; Thangjam, GS; Panzitt, K; Tallman, CT; Butler, C; Sana, TR; Fischer, SM; Sica, G; Brat, DJ; Shi, H; Palapattu, GS; Lotan, Y; Weizer, AZ; Terris, MK; Shariat, SF; Michailidis, G; Sreekumar, A Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.
Cancer Res. 2011; 71(24):7376-7386 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Roscigno, M; Brausi, M; Heidenreich, A; Lotan, Y; Margulis, V; Shariat, SF; Van Poppel, H; Zigeuner, R Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.
Eur Urol. 2011; 60(4): 776-783.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Shariat, SF; Savage, C; Chromecki, TF; Sun, M; Scherr, DS; Lee, RK; Lughezzani, G; Remzi, M; Marberger, MJ; Karakiewicz, PI; Vickers, AJ Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.
CANCER-AM CANCER SOC. 2011; 117(13): 2892-2897. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2010

Balic, M; Williams, A; Dandachi, N; Cote, RJ Micrometastasis: detection methods and clinical importance.
Cancer Biomark. 2010; 9(1-6):397-419
Web of Science PubMed FullText FullText_MUG

 

Becker, M; Szarvas, T; Wittschier, M; Vom Dorp, F; Tötsch, M; Schmid, KW; Rübben, H; Ergün, S Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer.
Cancer. 2010; 116(19):4502-4512 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum